The WACC of Theravance Biopharma Inc (TBPH) is 7.8%.
| Range | Selected | |
| Cost of equity | 6.00% - 9.90% | 7.95% |
| Tax rate | 1.30% - 2.40% | 1.85% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 6.0% - 9.6% | 7.8% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.47 | 0.9 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.00% | 9.90% |
| Tax rate | 1.30% | 2.40% |
| Debt/Equity ratio | 0.06 | 0.06 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 6.0% | 9.6% |
| Selected WACC | 7.8% | |